SOURCE: Xtalks

Xtalks Webinars

August 27, 2015 07:00 ET

Clinical Trial Opportunities in Russia and Ukraine, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - August 27, 2015) - This webinar will explore how to enable a well-defined, smooth approach to clinical trials in Russia and Ukraine that mitigates risk from beginning to end. Mathilde Niessen, Distribution Project Manager at Fisher Clinical Services, will share her perspective and suggest best practice initiatives on how to achieve success in clinical research in this region. The live one-hour session takes place on Tuesday, September 15, 2015 at 11am EDT (4pm BST/ GMT +1).

Running clinical trials in Brazil, Russia, India and China (BRIC) remains a firm priority for global pharmaceutical and biotech companies pursuing clinical research. Despite recent geopolitical unrest, Russia and its surrounding countries, including the Ukraine, remain popular geographies for companies wishing to conduct research in this region alone or as part of a multinational multi-center clinical trial.

Russia has the 7th largest pharmaceutical market and the 9th largest population in the world. In 2014 the Ministry of Health of the Russian Federation approved about 750 new clinical trials across all leading therapeutic areas. A recent survey by Ernst & Young found that 80% of leading drug manufacturers and distributors continue, on the whole, to pursue their plans for business development in the Russian market in spite of the unstable political and economic situation and current sanctions against Russia¹.

Key topics:

  • Opportunities presented by this geography and what makes it conducive to clinical research
  • Challenges including Clinical Trial Authorization (CTA) and regulatory timelines; importation requirements; vast country infrastructure; supply chain logistics in regions experiencing conflict; extreme temperature conditions and climate zones; regulatory changes
  • Best practices on how to address these challenges
  • The importance of a well-defined communication plan

To learn more about this event visit: Clinical Trial Opportunities in Russia and Ukraine

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

¹ The Russian pharmaceutical industry amid economic sanctions, Ernst & Young, June 2015

Image Available: http://www.marketwire.com/library/MwGo/2015/8/25/11G051816/Images/FCS--2-line-Logo-CMYK-Outli-1377225815530.jpg

Contact Information